MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas

Pituitary adenoma (PA) accounts for 10–15% of all intracranial neoplasms. Even though most pituitary adenomas are benign, it is known that almost 35% of them exhibit an aggressive clinical course, including rapid proliferative activity and invasion of neighboring tissues. MicroRNAs (miRNAs) are shor...

Descripción completa

Detalles Bibliográficos
Autores principales: Beylerli, Ozal, Beeraka, Narasimha M., Gareev, Ilgiz, Pavlov, Valentin, Yang, Guang, Liang, Yanchao, Aliev, Gjumrakch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583927/
https://www.ncbi.nlm.nih.gov/pubmed/33023145
http://dx.doi.org/10.3390/ijms21197287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583927/
https://www.ncbi.nlm.nih.gov/pubmed/33023145
http://dx.doi.org/10.3390/ijms21197287

Ejemplares similares